Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Value to shareholders
View:
Post by winnerswing on Apr 13, 2023 9:14am

Value to shareholders

Someone can explain why value to shareholders has been created again during Q4 2022 while a net loss has been recorded?
Comment by prophetoffactz on Apr 13, 2023 9:20am
Q4 is typically the weakest quarter. Individual quarters are lumpy. You need to look at annual results. 2022 was another record year with 10% growth which is consistent with the historic growth rate of the last decade.  "Cash generated from operations of $6,637,000, for the full year 2022 compared to $3,510,000 in 2021." News release The pipeline continues to advance from ...more  
Comment by winnerswing on Apr 13, 2023 9:26am
No, I mean value created from Q3 2022 to Q4 2022: the shareholder value creation from the good 2022 year is already included in the Q3 results.
Comment by prophetoffactz on Apr 13, 2023 9:32am
Stocks aren't valued on the basis of a single quarter. Stocks are valued based on the next 10 years into the future, etc. Ignore a given quarter. One quarter in the next ten years is only 2.5% of the stocks value, in a sense.   Q4 is typically the weakest quarter. Individual quarters are lumpy. You need to look at annual results. 2022 was another record year with 10% growth which is ...more  
Comment by winnerswing on Apr 13, 2023 9:37am
You know what I mean...
Comment by prophetoffactz on Apr 13, 2023 9:48am
"You know what I mean..." No I don't. If you want to value a business based on a single quarter knock yourself out.  Stocks aren't valued on the basis of a single quarter. Stocks are valued based on the next 10 years into the future, etc. Ignore a given quarter. One quarter in the next ten years is only 2.5% of the stocks value, in a sense.   Q4 is typically the ...more  
Comment by winnerswing on Apr 13, 2023 11:12am
OK, I see. You do not know how to compute shareholder value variation. OK.
Comment by Hopeforthebest on Apr 13, 2023 12:14pm
We have had 2 straight qrtrs of decreased growth, decreased r&d and increased spending, that is not value that in the banking world is classified as a recession. As for the piupeline, the pipeline you mention time and time again is only of value if one, meaning gagnon, lives up to the timelines and commitment he has previously amde. Well we all know that has not happened, so again no ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities